PRTK Annual Accounts Payable
$5.31 M
-$86.00 K-1.59%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual accounts payable is $5.31 million, with the most recent change of -$86.00 thousand (-1.59%) on December 31, 2022. During the last 3 years, it has risen by +$1.19 million (+28.96%).PRTK Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Accounts Payable
$2.95 M
-$2.37 M-44.51%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly accounts payable is $2.95 million, with the most recent change of -$2.37 million (-44.51%) on June 30, 2023. Over the past year, it has increased by +$694.00 thousand (+30.75%).PRTK Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.6% | +30.8% |
| 3 y3 years | +29.0% | -47.1% |
| 5 y5 years | +49.3% | +10.7% |
PRTK Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -1.6% | -63.6% |
Paratek Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $2.95 M(-44.5%) |
| Mar 2023 | - | $5.32 M(+0.2%) |
| Dec 2022 | $5.31 M(-1.6%) | $5.31 M(-34.5%) |
| Sept 2022 | - | $8.11 M(+259.2%) |
| June 2022 | - | $2.26 M(-51.9%) |
| Mar 2022 | - | $4.70 M(-12.9%) |
| Dec 2021 | $5.39 M(+197.5%) | $5.39 M(+8.1%) |
| Sept 2021 | - | $4.99 M(+92.7%) |
| June 2021 | - | $2.59 M(-36.0%) |
| Mar 2021 | - | $4.04 M(+123.1%) |
| Dec 2020 | $1.81 M(-56.0%) | $1.81 M(-40.3%) |
| Sept 2020 | - | $3.04 M(-45.5%) |
| June 2020 | - | $5.58 M(+741.5%) |
| Mar 2020 | - | $663.00 K(-83.9%) |
| Dec 2019 | $4.12 M(+96.9%) | $4.12 M(+4.0%) |
| Sept 2019 | - | $3.96 M(+57.5%) |
| June 2019 | - | $2.51 M(-18.7%) |
| Mar 2019 | - | $3.09 M(+47.8%) |
| Dec 2018 | $2.09 M(-41.2%) | $2.09 M(-59.1%) |
| Sept 2018 | - | $5.11 M(+91.6%) |
| June 2018 | - | $2.67 M(-29.0%) |
| Mar 2018 | - | $3.76 M(+5.7%) |
| Dec 2017 | $3.56 M(-19.5%) | $3.56 M(+24.4%) |
| Sept 2017 | - | $2.86 M(-12.7%) |
| June 2017 | - | $3.27 M(+54.6%) |
| Mar 2017 | - | $2.12 M(-52.1%) |
| Dec 2016 | $4.42 M(+476.8%) | $4.42 M(-20.5%) |
| Sept 2016 | - | $5.56 M(-29.7%) |
| June 2016 | - | $7.91 M(+80.5%) |
| Mar 2016 | - | $4.38 M(+472.2%) |
| Dec 2015 | $766.00 K(+56.6%) | $766.00 K(>+9900.0%) |
| Sept 2015 | - | $4000.00(-98.8%) |
| June 2015 | - | $321.00 K(+6320.0%) |
| Mar 2015 | - | $5000.00(-99.0%) |
| Dec 2014 | $489.00 K | $489.00 K(+9.4%) |
| Sept 2014 | - | $447.00 K(-57.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $1.04 M(+17.8%) |
| Mar 2014 | - | $886.00 K(+114.5%) |
| Dec 2013 | $413.00 K(-58.7%) | $413.00 K(-78.2%) |
| Sept 2013 | - | $1.90 M(+404.0%) |
| June 2013 | - | $376.00 K(-60.6%) |
| Mar 2013 | - | $954.00 K(-4.7%) |
| Dec 2012 | $1.00 M(+1.4%) | $1.00 M(-9.0%) |
| Sept 2012 | - | $1.10 M(+8.7%) |
| June 2012 | - | $1.01 M(+4.5%) |
| Mar 2012 | - | $968.00 K(-1.9%) |
| Dec 2011 | $987.00 K(+65.1%) | $987.00 K(+52.6%) |
| Sept 2011 | - | $647.00 K(-45.7%) |
| June 2011 | - | $1.19 M(+56.9%) |
| Mar 2011 | - | $759.00 K(+26.9%) |
| Dec 2010 | $598.00 K(-17.9%) | $598.00 K(-60.7%) |
| Sept 2010 | - | $1.52 M(+73.0%) |
| June 2010 | - | $879.00 K(+2.0%) |
| Mar 2010 | - | $862.00 K(+18.4%) |
| Dec 2009 | $728.00 K(+26.6%) | $728.00 K(+20.2%) |
| Sept 2009 | - | $605.50 K(-44.5%) |
| June 2009 | - | $1.09 M(-17.0%) |
| Mar 2009 | - | $1.31 M(+128.6%) |
| Dec 2008 | $575.00 K(-86.3%) | $575.00 K(-75.0%) |
| Sept 2008 | - | $2.30 M(+36.9%) |
| June 2008 | - | $1.68 M(-55.2%) |
| Mar 2008 | - | $3.75 M(-10.7%) |
| Dec 2007 | $4.20 M(+74.0%) | $4.20 M(-8.8%) |
| Sept 2007 | - | $4.60 M(+66.1%) |
| June 2007 | - | $2.77 M(-35.0%) |
| Mar 2007 | - | $4.26 M(+76.5%) |
| Dec 2006 | $2.41 M(-6.7%) | $2.41 M(+14.2%) |
| Sept 2006 | - | $2.11 M(-13.8%) |
| June 2006 | - | $2.45 M(-24.5%) |
| Mar 2006 | - | $3.25 M(+25.6%) |
| Dec 2005 | $2.58 M(+82.9%) | $2.58 M(+82.9%) |
| Dec 2004 | $1.41 M | $1.41 M |
FAQ
- What is Paratek Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual accounts payable year-on-year change?
- What is Paratek Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly accounts payable year-on-year change?
What is Paratek Pharmaceuticals annual accounts payable?
The current annual accounts payable of PRTK is $5.31 M
What is the all time high annual accounts payable for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual accounts payable is $5.39 M
What is Paratek Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, PRTK annual accounts payable has changed by -$86.00 K (-1.59%)
What is Paratek Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of PRTK is $2.95 M
What is the all time high quarterly accounts payable for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly accounts payable is $8.11 M
What is Paratek Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, PRTK quarterly accounts payable has changed by +$694.00 K (+30.75%)